Cargando…

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

BACKGROUND: There is a need for postmarketing evidence generation for novel biologics and biosimilars. OBJECTIVE: To assess the feasibility, strengths, and limitations of the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Distributed Research Network (DRN) to examine the utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jie, Sridhar, Gayathri, Barr, Charles E., Eichelberger, Bernadette, Lockhart, Catherine M., Marshall, James, Clewell, Jerry, Accortt, Neil A., Curtis, Jeffrey R., Holmes, Cynthia, McMahill-Walraven, Cheryl N., Brown, Jeffrey S., Haynes, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391097/ https://www.ncbi.nlm.nih.gov/pubmed/32223608 http://dx.doi.org/10.18553/jmcp.2020.26.4.417

Ejemplares similares

1070 Validation of Febrile Seizures Identified in the Mini-Sentinel Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System
por: Kawai, Alison Tse, et al.
Publicado: (2014)

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018)

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
por: Jutkowitz, Eric, et al.
Publicado: (2020)

Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System
por: Yih, Weiling Katherine, et al.
Publicado: (2015)

Synthesis-Dependent Strand Annealing in Meiosis
por: McMahill, Melissa S, et al.
Publicado: (2007)

Characteristics of new adult users of mepolizumab with asthma in the USA
por: Wu, Ann Chen, et al.
Publicado: (2021)

Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
por: Brat, Gabriel A, et al.
Publicado: (2018)

Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults
por: Harris, Daniel A., et al.
Publicado: (2023)

Adherence patterns in naïve and prevalent use of infliximab and its biosimilar
por: Alanaeme, Chibuike J., et al.
Publicado: (2022)

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US
por: Jin, Ran, et al.
Publicado: (2021)

Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
por: Mendelsohn, Aaron B., et al.
Publicado: (2021)

Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus
por: Huang, Ting-Ying, et al.
Publicado: (2022)

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)
por: Jin, Ran, et al.
Publicado: (2023)

Antibiotic dispensing following pediatric visits in the US emergency departments and outpatient settings from 2006 to 2016
por: Agiro, Abiy, et al.
Publicado: (2019)

Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis
por: Shinde, Mayura, et al.
Publicado: (2022)

How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
por: Triplitt, Curtis, et al.
Publicado: (2017)

The Risk of Febrile Seizures Following Influenza and 13-Valent Pneumococcal Conjugate Vaccines
por: Baker, Meghan, et al.
Publicado: (2017)

SOAT1 missense variant in two cats with sebaceous gland dysplasia
por: Kiener, Sarah, et al.
Publicado: (2023)

Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life
por: Ashana, Deepshikha Charan, et al.
Publicado: (2019)

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
por: Lloyd, Patricia C., et al.
Publicado: (2022)

Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment
por: Hayes, Kaleen N., et al.
Publicado: (2023)

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2019)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

The U.S. COVID-19 County Policy Database: a novel resource to support pandemic-related research
por: Hamad, Rita, et al.
Publicado: (2022)

Biosimilar infliximab use in paediatric IBD
por: Richmond, Lisa, et al.
Publicado: (2018)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Biosimilars in dermatology
por: Mazur, Małgorzata, et al.
Publicado: (2015)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018)

Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
por: Bansback, Nick, et al.
Publicado: (2020)

Management of specialty drugs, specialty pharmacies and biosimilars in the United States
por: Brook, Richard A., et al.
Publicado: (2019)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
por: Uifălean, Alina, et al.
Publicado: (2018)

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

AMCP Partnership Forum: Biosimilars—policy, practice, and postmarketing surveillance to support treatment and coverage decisions
Publicado: (2021)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla, Prashanth, et al.
Publicado: (2018)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

Developing a Standardized and Reusable Method to Link Distributed Health Plan Databases to the National Death Index: Methods Development Study Protocol
por: Fuller, Candace C, et al.
Publicado: (2020)

Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial
por: Pokorney, Sean D., et al.
Publicado: (2022)

Surveillance of serious adverse events following immunization in resource poor settings
por: Breugelmans, Gabrielle J, et al.
Publicado: (2011)

The Necessity of a Nationwide Surveillance System of Serious BCG Adverse Reactions
por: Cho, Hye-Kyung
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qvt608dq5ku32umqh8aijk21bb